acquired purpura fulminansResearch
A recent study highlights a case of acquired immune thrombotic thrombocytopenic purpura (aTTP) following transaxillary transcatheter aortic valve replacement, emphasizing its potential as a rare and life-threatening hematologic emergency. This discovery may inform clinical practices and patient management strategies.
acquired immune thrombotic thrombocytopenic purpura following transaxillary transcatheter aortic valve replacement a rare life threatening hematologic emergency
Original title: “Acquired Immune Thrombotic Thrombocytopenic Purpura Following Transaxillary Transcatheter Aortic Valve Replacement: A Rare Life-Threatening Hematologic Emergency.”